Natural Product (NP) Details
General Information of the NP (ID: NP1549) | |||||
---|---|---|---|---|---|
Name |
Naringenin
|
||||
Synonyms |
5,7-Dihydroxy-2-(4-hydroxyphenyl)chroman-4-one; 67604-48-2; 4',5,7-Trihydroxyflavanone; Naringenine; (+/-)-Naringenin; naringetol; 480-41-1; salipurpol; (-)-Naringenin; NARIGENIN; Salipurol; 5,7,4'-Trihydroxyflavanone; 93602-28-9; (S)-Naringenin; BE-14348A; NSC 34875; ( inverted exclamation markA)-Naringenin; CHEMBL32571; MLS000738094; MLS000028739; CHEBI:50202; Flavanone, 4',5,7-trihydroxy-; FTVWIRXFELQLPI-UHFFFAOYSA-N; NSC34875; NSC11855; MFCD00006844; SMR000059039; AK122638; NSC 11855; 4',7-Trihydroxyflavanone
Click to Show/Hide
|
||||
Species Origin | Potentilla discolor ... | Click to Show/Hide | |||
Potentilla discolor | |||||
Disease | Hepatitis C virus infection [ICD-11: 1E51] | Phase 1 | [1] | ||
Structure |
Click to Download Mol2D MOL |
||||
Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product | |||||
Formula |
C15H12O5
|
||||
PubChem CID | |||||
Canonical SMILES |
C1C(OC2=CC(=CC(=C2C1=O)O)O)C3=CC=C(C=C3)O
|
||||
InChI |
1S/C15H12O5/c16-9-3-1-8(2-4-9)13-7-12(19)15-11(18)5-10(17)6-14(15)20-13/h1-6,13,16-18H,7H2
|
||||
InChIKey |
FTVWIRXFELQLPI-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 67604-48-2
|
||||
Herb ID | |||||
ETMC ID | |||||
SymMap ID | |||||
TCMSP ID | |||||
TTD Drug ID |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. A List of Drug(s) Whose Efficacy can be Enhanced by This NP | ||||||
ABT-737 | Ovarian cancer | Click to Show/Hide the Molecular Data of This Drug | ||||
Augmenting Drug Sensitivity | Click to Show/Hide | |||||
Representative Experiment Reporting the Effect of This Combination | [2] | |||||
Detail(s) | Combination Info click to show the detail info of this combination | |||||
Molecule(s)
Regulation |
Down-regulation | Phosphorylation | AKT1 | Molecule Info |
Pathway MAP
|
|
Up-regulation | Cleavage | CASP3 | Molecule Info |
Pathway MAP
|
||
Up-regulation | Cleavage | PARP1 | Molecule Info |
Pathway MAP
|
||
In-vitro Model | SGC-7901 | CVCL_0520 | Human gastric cancer | Homo sapiens | ||
Experimental
Result(s) |
ABT-737 in combination with naringenin showed enhanced anticancer effects on gastric cancer cells. |
Target and Pathway | ||||
---|---|---|---|---|
Target(s) | Aromatase (CYP19A1) | Molecule Info | [3] | |
Cytochrome P450 1B1 (CYP1B1) | Molecule Info | [4] | ||
Estradiol 17 beta-dehydrogenase 1 (17-beta-HSD1) | Molecule Info | [5] | ||
Lactoylglutathione lyase (GLO1) | Molecule Info | [6] | ||
Oestrogen receptor beta (ESR2) | Molecule Info | [7] | ||
BioCyc | Superpathway of steroid hormone biosynthesis | Click to Show/Hide | ||
2 | Estradiol biosynthesis II | |||
3 | Estradiol biosynthesis I | |||
4 | Superpathway of tryptophan utilization | |||
5 | Superpathway of melatonin degradation | |||
6 | Melatonin degradation I | |||
7 | Methylglyoxal degradation I | |||
KEGG Pathway | Steroid hormone biosynthesis | Click to Show/Hide | ||
2 | Metabolic pathways | |||
3 | Ovarian steroidogenesis | |||
4 | Tryptophan metabolism | |||
5 | Metabolism of xenobiotics by cytochrome P450 | |||
6 | Chemical carcinogenesis | |||
7 | MicroRNAs in cancer | |||
8 | Estrogen signaling pathway | |||
9 | Prolactin signaling pathway | |||
10 | Pyruvate metabolism | |||
NetPath Pathway | FSH Signaling Pathway | Click to Show/Hide | ||
2 | TSH Signaling Pathway | |||
3 | IL4 Signaling Pathway | |||
4 | TGF_beta_Receptor Signaling Pathway | |||
5 | TCR Signaling Pathway | |||
Panther Pathway | Androgen/estrogene/progesterone biosynthesis | Click to Show/Hide | ||
Pathwhiz Pathway | Androgen and Estrogen Metabolism | Click to Show/Hide | ||
2 | Pyruvaldehyde Degradation | |||
3 | Pyruvate Metabolism | |||
Pathway Interaction Database | Plasma membrane estrogen receptor signaling | Click to Show/Hide | ||
2 | Validated nuclear estrogen receptor beta network | |||
3 | Validated nuclear estrogen receptor alpha network | |||
Reactome | Endogenous sterols | Click to Show/Hide | ||
2 | The canonical retinoid cycle in rods (twilight vision) | |||
3 | Nuclear Receptor transcription pathway | |||
4 | Pyruvate metabolism | |||
WikiPathways | Metapathway biotransformation | Click to Show/Hide | ||
2 | Tryptophan metabolism | |||
3 | Oxidation by Cytochrome P450 | |||
4 | Ovarian Infertility Genes | |||
5 | Metabolism of steroid hormones and vitamin D | |||
6 | FSH signaling pathway | |||
7 | Integrated Breast Cancer Pathway | |||
8 | Phase 1 - Functionalization of compounds | |||
9 | Estrogen metabolism | |||
10 | Benzo(a)pyrene metabolism | |||
11 | Tamoxifen metabolism | |||
12 | Nuclear Receptors Meta-Pathway | |||
13 | Estrogen Receptor Pathway | |||
14 | Sulindac Metabolic Pathway | |||
15 | Arylhydrocarbon receptor (AhR) signaling pathway | |||
16 | miR-targeted genes in muscle cell - TarBase | |||
17 | miR-targeted genes in lymphocytes - TarBase | |||
18 | miR-targeted genes in epithelium - TarBase | |||
19 | miR-targeted genes in adipocytes - TarBase | |||
20 | Steroid Biosynthesis | |||
21 | Prostate Cancer | |||
22 | SIDS Susceptibility Pathways | |||
23 | Integrated Pancreatic Cancer Pathway | |||
24 | Nuclear Receptors |